Download PDF
CC BY-NC-ND 4.0 · Avicenna J Med 2014; 04(03): 71-73
DOI: 10.4103/2231-0770.133338
CASE REPORT

A case of septicemia due to Chyresobacterium indologenes producing bla NDM-1

Atul Khajuria
Department of Microbiology, Armed Forces Medical College, Pune, Maharashtra, India
,
Ashok Kumar Praharaj
Department of Microbiology, AIIMS, Bhubaneswar, Odisha, India
,
Mahadevan Kumar
Department of Microbiology, Armed Forces Medical College, Pune, Maharashtra, India
,
Naveen Grover
Department of Microbiology, Armed Forces Medical College, Pune, Maharashtra, India
› Author Affiliations
› Further Information
  PDF Download Permissions and Reprints

Abstract

A multidrug resistant Chyresobacterium indologenes was isolated from blood in a case of septicemia. The organism was resistant to carbapenems and was positive for bla NDM-1 ; transferable through plasmid.

Keywords

bla NDM-1 - Chyresobacterium indologenes - IncN type


Publication History

Article published online:
09 August 2021

© 2014. Syrian American Medical Society. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Bhuyar G, Jain S, Shah H, Mehta VK. Urinary tract infection by Chryseobacterium indologenes. Indian J Med Microbiol 2012;30:370-2.
  • 2 Lin YT, Jeng YY, Lin ML, Yu KW, Wang FD, Liu CY. Clinical and microbiological characteristics of Chryseobacterium indologenes bacteremia. J Microbiol Immunol Infect 2010;43:498-505.
  • 3 Cascio A, Stassi G, Costa GB, Crisafulli G, Rulli I, Ruggeri C, et al. Chryseobacterium indologenes bacteraemia in a diabetic child. J Med Microbiol 2005;54:677-80.
  • 4 Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: twenty Second Informational Supplement M100-S22. Wayne, PA, USA: CLSI; 2012.
  • 5 European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for Interpretation of MICs and zone diameters (Version 2, January 1, 2012). Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/Breakpoint_table_v_2.0_120221.pdf. [Last accessed on 2012 Feb 23].
  • 6 Khajuria A, Praharaj AK, Grover N, Kumar M. First report of an Enterobacter ludwigii isolate coharboring NDM-1 and OXA-48 carbapenemases. Antimicrob Agents Chemother 2013;57:5189-90.
  • 7 Kieser T. Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 1984;12:19-36.
  • 8 Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005;63:219-28.
  • 9 Shah S, Sarwar U, King EA, Lat A. Chryseobacterium indologenes subcutaneous port-related bacteremia in a liver transplant patient. Transpl Infect Dis 2012;14:398-402.
  • 10 Bellais S, Poirel L, Leotard S, Naas T, Nordmann P. Genetic diversity of carbapenem-hydrolyzing metallo-beta-lactamases from Chryseobacterium (Flavobacterium) indologenes. Antimicrob Agents Chemother 2000;44:3028-34.
  • 11 Zeba B, De Luca F, Dubus A, Delmarcelle M, Simporé J, Nacoulma OG, et al. IND-6, a highly divergent IND-type metallo-beta-lactamase from Chryseobacterium indologenes strain 597 isolated in Burkina Faso. Antimicrob Agents Chemother 2009;53:4320-6.